| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2009 | WO2009114716A2 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling |
| 09/17/2009 | WO2009114712A2 Assays for diagnosing and evaluating treatment options for pompe disease |
| 09/17/2009 | WO2009114695A1 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/17/2009 | WO2009114685A2 O-desmethylvenlafaxine salts |
| 09/17/2009 | WO2009114677A1 Pyridazine derivatives as factor xia inhibitors |
| 09/17/2009 | WO2009114658A2 Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer |
| 09/17/2009 | WO2009114651A2 Use of '-thio-2'-deoxynucleosides as anri orthopoxvirus agents |
| 09/17/2009 | WO2009114650A1 Methods and compositions for treating inflammation and inflammation-related pathologies |
| 09/17/2009 | WO2009114601A2 Preparation of lenalidomide |
| 09/17/2009 | WO2009114575A1 Tricyclic spiro pyrimidine derivatives as histamine h4 ligand |
| 09/17/2009 | WO2009114566A1 Novel compounds as cannabinoid receptor ligands |
| 09/17/2009 | WO2009114552A1 Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| 09/17/2009 | WO2009114540A2 Vitamin d compounds and methods for reducing ocular hypertension (oht) |
| 09/17/2009 | WO2009114538A1 Aminophosphonate carriers for liposome-based drug release systems |
| 09/17/2009 | WO2009114533A2 Modulation of blood brain barrier permeability |
| 09/17/2009 | WO2009114525A1 Methods and compositions for controlled delivery of phytochemical agents |
| 09/17/2009 | WO2009114521A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 09/17/2009 | WO2009114516A1 Therapy for disorders of the proximal digestive tract |
| 09/17/2009 | WO2009114512A1 Azetidine and cyclobutane derivatives as jak inhibitors |
| 09/17/2009 | WO2009114476A1 Compositions comprising survivin sirna and methods of use thereof |
| 09/17/2009 | WO2009114475A2 Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use |
| 09/17/2009 | WO2009114470A2 Tetrahydroindole and tetrahdyroindazole as hsp90 inhibitors containing a zinc binding moiety |
| 09/17/2009 | WO2009114459A2 Anti-neoplastic combination therapeutic regimen involving co-disruption of parp pathway and mre11/rad50/nbs1 complex and compositons useful therein |
| 09/17/2009 | WO2009114373A1 Treatment for ocular-related disorders |
| 09/17/2009 | WO2009114368A2 Activated nitric oxide donors and methods of making and using thereof |
| 09/17/2009 | WO2009114325A2 Methotrexate adjuvants to reduce toxicity and methods for using the same |
| 09/17/2009 | WO2009114313A2 Methods for synthesizing antiviral compounds |
| 09/17/2009 | WO2009114307A1 Therapeutic compounds |
| 09/17/2009 | WO2009114298A1 Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors |
| 09/17/2009 | WO2009114201A2 Steroidal ligands and their use in gene switch modulation |
| 09/17/2009 | WO2009114181A2 Substituted heterocycle fused gamma-carbolines solid |
| 09/17/2009 | WO2009114173A1 Azabicyclo [3. 2. i] octyl derivatives as 11 beta-hsdl modulators |
| 09/17/2009 | WO2009114143A1 Treatment and prophylaxis of epilepsy and febrile seizures |
| 09/17/2009 | WO2009114139A2 Methods, compositions, and kits for treating pain and pruritis |
| 09/17/2009 | WO2009114136A2 Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents |
| 09/17/2009 | WO2009114126A1 Piperlongumine and piperlongumine analogs for use in the treatment of cancer |
| 09/17/2009 | WO2009114118A2 Oral pharmaceutical compositions of buprenorphine and method of use |
| 09/17/2009 | WO2009114098A2 Methods of treating hyperacidic disorders |
| 09/17/2009 | WO2009114090A2 Method for inhibiting the build-up of arterial plaque by administering fullerenes |
| 09/17/2009 | WO2009114089A2 Using fullerenes to enhance and stimulate hair growth |
| 09/17/2009 | WO2009114088A2 Fullerene therapies for inflammation |
| 09/17/2009 | WO2009114087A2 A method for treating pruritus by administering fullerenes |
| 09/17/2009 | WO2009114084A2 Method for treating wounds by administering fullerenes |
| 09/17/2009 | WO2009114080A2 Processes for preparing enantiomerically pure diol and dioxolane compounds |
| 09/17/2009 | WO2009114010A1 Macrocyclic lactone compounds and methods for their use |
| 09/17/2009 | WO2009113989A1 Compositions and methods of use of compounds to increase cancer patient survival time |
| 09/17/2009 | WO2009113983A1 Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions |
| 09/17/2009 | WO2009113952A1 Phytol as a cholesterol lowering agent |
| 09/17/2009 | WO2009113950A1 Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist |
| 09/17/2009 | WO2009113910A1 Antiinflammatory and antiallergic gel |
| 09/17/2009 | WO2009113902A1 Antitumoral terpenoid pharmaceutical composition 'abisilin' exhibiting angiogenesis-inhibiting action |
| 09/17/2009 | WO2009113810A2 Pharmaceutical composition, use thereof, and method for the treatment or prevention of allergic and autoimmune diseases |
| 09/17/2009 | WO2009113741A2 A combination drug for treating vascular disorder |
| 09/17/2009 | WO2009113736A1 Mmp-2 and/or mmp-9 inhibitor |
| 09/17/2009 | WO2009113696A1 Crystal of benzimidazole compound |
| 09/17/2009 | WO2009113600A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | WO2009113594A1 Agent and food for prevention/amelioration of functional gastrointestinal disorders |
| 09/17/2009 | WO2009113579A1 Double-stranded nucleic acid molecule suitable for prevention or treatment of cancer, cancer cell proliferation inhibitor, and pharmaceutical preparation |
| 09/17/2009 | WO2009113569A1 Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
| 09/17/2009 | WO2009113560A1 Fused heterocyclic compound |
| 09/17/2009 | WO2009113512A1 Socs3 expression promoter, drug and food containing the same and method of promoting the expression of socs3 |
| 09/17/2009 | WO2009113504A1 Patch |
| 09/17/2009 | WO2009113480A1 Therapeutic agent for cerebral infarction |
| 09/17/2009 | WO2009113438A1 Antibacterial composition for medical use and medical device |
| 09/17/2009 | WO2009113436A1 Method for enhancing the anti-cancer activity of radioactive ray by using fgf33 gene inhibitor in combination with irradiation with the radioactive ray, and method for reducing adverse side effects of radioactive ray |
| 09/17/2009 | WO2009113435A1 Sugar derivative preparation |
| 09/17/2009 | WO2009113423A1 Bicyclic pyrrole compound |
| 09/17/2009 | WO2009113420A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
| 09/17/2009 | WO2009113404A1 Inhibitor for growth of bacteria of genus legionella, bath agent and cleaning agent |
| 09/17/2009 | WO2009113403A1 Anti-methicillin-resistant staphylococcus aureus agent and anti-vancomycin-resistant enterococcus agent |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009113287A1 Aromatic antihypertensive agent, and method for lowering blood pressure in mammal |
| 09/17/2009 | WO2009113109A1 New phenanthrylphenol linked pyrrolo[2,l-c][l,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof |
| 09/17/2009 | WO2009113091A2 Pharmaceutical compositions comprising valsartan |
| 09/17/2009 | WO2009113090A2 Process for preparing an oral formulation of an acid-sensitive benzimidazole drug |
| 09/17/2009 | WO2009113086A2 Ibuprofen liquid fill formulation, dosage form thereof and a process for its preparation |
| 09/17/2009 | WO2009113085A1 Novel benzimidazole linked pyrrolo[2,1-q[1,4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof |
| 09/17/2009 | WO2009113084A1 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 09/17/2009 | WO2009113061A1 Humidity-resistant drug formulations and methods of preparation thereof |
| 09/17/2009 | WO2009113051A2 Oral modified-release formulations containing thiazepines |
| 09/17/2009 | WO2009113033A2 Linear and cyclic guanidine derivatives, method of preparation and uses thereof |
| 09/17/2009 | WO2009112954A2 Processes for the preparation of bosentan and related compounds using novel intermediates |
| 09/17/2009 | WO2009112874A1 Modified release composition comprising doxofylline |
| 09/17/2009 | WO2009112870A1 Pharmaceutical composition comprising rosuvastatin calcium and magnesium carbonate hydroxide pentahydrate as a stabilizer |
| 09/17/2009 | WO2009112845A1 Amido-thiophene compounds and their use |
| 09/17/2009 | WO2009112839A1 Compounds |
| 09/17/2009 | WO2009112832A1 Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009112800A1 Losartan composition |
| 09/17/2009 | WO2009112758A2 Novel use of zinc n-acetyltaurinate |
| 09/17/2009 | WO2009112740A2 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production |
| 09/17/2009 | WO2009112703A1 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/17/2009 | WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | WO2009112679A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112674A2 Compounds for use in the treatment of neuropathic pain |
| 09/17/2009 | WO2009112653A2 Cosmetic and/or dermatological composition |
| 09/17/2009 | WO2009112652A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112651A1 Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/17/2009 | WO2009112625A1 Use of microrna-203 and systems for expressing same in the manufacture of cancer drugs |